Dr Sarah Zhao has recently published a paper in Clinical Lymphoma, Myeloma & Leukaemia titled "Real-World Comparison of Treatment Outcomes for Multiple Myeloma in Elderly Transplant Ineligible Patients Receiving First-Line VRd, Rd and VCd: Results From the Australian and New Zealand Myeloma and Related Diseases Registry". This study used real-world MRDR data to evaluate the efficacy of three first-line therapy regimens in elderly transplant ineligible newly diagnosed multiple myeloma patients.
Thank you to all patients, MRDR site staff and investigators for your contribution to this, and congratulations to Dr. Sarah Zhao on this publication!